Repaglinide Oral Tablet 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Repaglinide: Oral tablet (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_20957.JPG
Repaglinide 0.5mg Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M  |  R21
Drug Image file DrugItem_18966.JPG
Repaglinide 0.5mg Tab
Paddock Laboratories Inc, a Perrigo Family
Pill Identification: P 240 
Drug Image file DrugItem_23472.JPG
Repaglinide 0.5mg Tab
Breckenridge Inc
Pill Identification: B853 
Drug Image file default-drug-image.png
Repaglinide 0.5mg Tab
Drug Image file default-drug-image.png
Repaglinide 0.5mg Tab

What is this Medicine?

REPAGLINIDE (re PAG lin ide) helps to treat type 2 diabetes. It helps to control blood sugar. Treatment is combined with diet and exercise.

CVS Pharmacy Patient Statistics for Repaglinide: Oral tablet(0.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Repaglinide 0.5mg Tablet

NDC: 003783121
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Protect from moisture
Store at controlled room temperature (between 68 and 77 degrees F)
Repaglinide 0.5mg Tablet
Drug Image file DrugItem_20957.JPG
Mylan Pharmaceuticals Inc.
Pill Identification: M  |  R21
Shape: round
Color: white

Reported Side Effects for Repaglinide 0.5mg Tablet

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Abnormal Heart Rhythm Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
1.8%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
1.8%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
16.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Repaglinide 0.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Repaglinide 0.5mg Tablet(Repaglinide)
Alcohol and Meglitinides(Repaglinide)
It is best to limit the ingestion of alcohol during use of this medicine. Alcohol can increase the risk for severe or prolonged low blood sugar. If you do choose to drink alcohol, make sure you do not take it on an empty stomach. Frequently monitor your blood sugar. Know the signs and symptoms of low blood sugar and how to treat them. Do not drive or operate machinery, or perform other hazardous tasks while ingesting alcohol.
Moderate Lifestyle Interaction
Grapefruit juice and Repaglinide 0.5mg Tablet(Repaglinide)
Grapefruit juice and Repaglinide(Repaglinide)
Although an interaction is possible, these medicines may be used together. Grapefruit juice may increase the actions of Repaglinide, by decreasing your blood sugar. If you use a blood sugar monitoring device at home, check your blood sugar regularly. You should also learn how to recognize the signs of low blood sugar. Report any significant changes in your blood sugar control to your health care provider.
Minor Lifestyle Interaction
Tobacco and Repaglinide 0.5mg Tablet(Repaglinide)
Tobacco and Meglitinides(Repaglinide)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Antidiabetic Agents (medicines used to treat diabetes) may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Repaglinide

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5